Literature DB >> 11526439

AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun.

C Grimm1, A Wenzel, A Behrens, F Hafezi, E F Wagner, C E Remé.   

Abstract

Apoptosis is essential for retinal development but it is also a major mode of cell loss in many human retinal dystrophies. High levels of visible light induce retinal apoptosis in mice and rats. This process is dependent on the induction of the transcription factor AP-1, a dimeric complex composed of c-Fos and c-Jun/JunD phosphoproteins. While c-Fos is essential, JunD is dispensable for light-induced photoreceptor apoptosis. Here we show that N-terminal phosphorylation of c-Jun, the other main partner of c-Fos in induced AP-1 complexes is not required for programmed cell death during retinal development in vivo and is also dispensable for photoreceptor apoptosis induced by the exogenous stimuli "excessive light" and N-nitroso-N-methylurea (MNU). Mice expressing a mutant c-Jun protein (JunAA) that cannot be phosphorylated at its N-terminus are apoptosis competent and their retina is not distinguishable from wild-type mice. Accordingly, Jun kinase, responsible for phosphorylation of wild-type c-Jun protein is at best only marginally induced by the apoptotic stimuli "light" and MNU. Complex composition of light-induced AP-1 complexes is similar in wild-type and JunAA mice. This shows that the mutant c-Jun protein can be part of the DNA binding complex AP-1 and demonstrates that induction of the DNA binding activity of AP-1 after light insult does not depend on N-terminal phosphorylation of c-Jun. Our results suggest that transactivation of target genes by phosphorylated c-jun/AP-1 is not required for MNU- or light-induced apoptosis of photoreceptor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526439     DOI: 10.1038/sj.cdd.4400871

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  11 in total

Review 1.  Why study rod cell death in retinal degenerations and how?

Authors:  C E Remé; C Grimm; F Hafezi; H P Iseli; A Wenzel
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

Review 2.  Potential implication of the chemical properties and bioactivity of nitrone spin traps for therapeutics.

Authors:  Frederick A Villamena; Amlan Das; Kevin M Nash
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

3.  Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy.

Authors:  Karine Merienne; James Friedman; Masayuki Akimoto; Gretta Abou-Sleymane; Chantal Weber; Anand Swaroop; Yvon Trottier
Journal:  Neurobiol Dis       Date:  2006-12-26       Impact factor: 5.996

4.  Prognostic significance of loss of c-fos protein in gastric carcinoma.

Authors:  Seon Pil Jin; Ji Hun Kim; Min A Kim; Han-Kwang Yang; Hee Eun Lee; Hye Seung Lee; Woo Ho Kim
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

5.  Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localization.

Authors:  Han Liu; Xuehong Deng; Y John Shyu; Jian Jian Li; Elizabeth J Taparowsky; Chang-Deng Hu
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

6.  Acetylcholinesterase (AChE) is an important link in the apoptotic pathway induced by hyperglycemia in Y79 retinoblastoma cell line.

Authors:  R Shehadeh Masha'our; R Heinrich; H J Garzozi; I Perlman
Journal:  Front Mol Neurosci       Date:  2012-06-06       Impact factor: 5.639

7.  Retinal degeneration modulates intracellular localization of CDC42 in photoreceptors.

Authors:  S R Heynen; N Tanimoto; S Joly; M W Seeliger; M Samardzija; C Grimm
Journal:  Mol Vis       Date:  2011-11-15       Impact factor: 2.367

8.  Neuronal c-Jun is required for successful axonal regeneration, but the effects of phosphorylation of its N-terminus are moderate.

Authors:  Crystal A Ruff; Nils Staak; Smriti Patodia; Mark Kaswich; Eridan Rocha-Ferreira; Clive Da Costa; Stephan Brecht; Milan Makwana; Xavier Fontana; Mariya Hristova; Prakasham Rumajogee; Matthias Galiano; Marion Bohatschek; Thomas Herdegen; Axel Behrens; Gennadij Raivich
Journal:  J Neurochem       Date:  2012-03-21       Impact factor: 5.372

Review 9.  Targeting HOX/PBX dimers in cancer.

Authors:  Richard Morgan; Mohamed El-Tanani; Keith D Hunter; Kevin J Harrington; Hardev S Pandha
Journal:  Oncotarget       Date:  2017-05-09

10.  A model to study complement involvement in experimental retinal degeneration.

Authors:  Camilla Mohlin; Kerstin Sandholm; Anders Kvanta; Kristina N Ekdahl; Kjell Johansson
Journal:  Ups J Med Sci       Date:  2018-02-13       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.